Post-COVID syndrome in cancer patients
https://doi.org/10.52485/19986173_2023_1_149
Abstract
Novel coronavirus infection is associated with the onset of persistent symptoms after illness that affect daily life, known as the post-COVID syndrome (PCS). The syndrome occupies a special category in oncological patients, reducing the quality of life, necessitating differential diagnosis with the progression or recurrence of a malignant disease in them. The article describes the literature review of PCS, a clinical case of PCS in an oncological patient, which arose during the dispensary observation of an oncologist. Given the severity of post-COVID disorders in a patient with cancer, the lack of knowledge of this phenomenon, the diagnosis was accompanied by certain difficulties.
Supporting agencies: Description of the clinical case is not had financial support
About the Authors
E. V. Kayukova
Chita State Medical Academy
Russian Federation
Russian Federation
672000; 39A Gorky str.; Chita
E. S. Bolotov
Chita State Medical Academy
Russian Federation
Russian Federation
672000; 39A Gorky str.; Chita
References
1. Lièvre A., Turpin A., Ray-Coquard I., et al.; GCO-002 CACOVID-19 collaborators/investigators. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study. Eur J Cancer. 2020. 141. DOI: 10.1016/j.ejca.2020.09.035.
2. Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine [Internet]. 2021. 38. Available from: https://pubmed.ncbi.nlm.nih.gov/34308300
3. Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) [Internet]. 2021. 45. DOI: 10.3389/fmed.2021.653516. Available from: https://pubmed.ncbi.nlm.nih.gov/34017846/
4. Khavinson V.K., Kuznik B.I., Volchkov V.A., et al. Effect of thymalin on adaptive immunity in complex therapy for patients with COVID-19. Clinical Medicine (Russian Journal). 2020. 988. DOI: 10.30629/0023-2149-2020-98-8-593-599.
5. Reese J., Blau H., Bergquist T., et al., and the RECOVER Consortium. Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs. medRxiv. 2022. 225. DOI: 10.1101/2022.05.24.22275398.
6. Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021. 125. DOI: 10.3390/vaccines9050497.
7. Silva Andrade B., Siqueira S., de Assis Soares W. R., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 134. DOI: 10.3390/v13040700
8. Wells A.U., Devaraj A., Desai S.R. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021. 294. DOI: 10.1148/radiol.2021204482.
9. Graham E.L., Clark J.R., Orban Z.S., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021. 85. DOI: 10.1002/acn3.51350.
10. Abbasi J. Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants. JAMA. 2021. 255. DOI: 10.1001/jama.2021.7212.
11. Weng J., Li Y., Li J., et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021. 65. DOI: 10.1016/S2468-1253(21)00076-5.
12. Chistyakova M.V., Zaitsev D.N., Govorin, A.V., Medvedeva N.A., Kurokhtina A.A. Post-COVID-19 syndrome: morpho-functional abnormalities of the heart and arrhythmias. Russian Journal of Cardiology. 2021. 267. DOI: 10.15829/1560-4071-2021-4485. in Russian.
13. Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021. 82. DOI: 10.1016/S2215-0366(20)30462-4
14. Diotallevi F., Mazzanti S., Properzi P., Olivieri S., Giacometti A., Offidani A. Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single centre. J Eur Acad Dermatol Venereol. 2022. 363. DOI: 10.1111/jdv.17803.
15. von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundström A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021. 93. DOI: 10.1182/bloodadvances.2020003968.
16. Pal R., Joshi A., Bhadada S.K., Banerjee M., Vaikkakara S., Mukhopadhyay S. Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence. Endocr Pract. 2022. 284. DOI: 10.1016/j.eprac.2022.02.003.
17. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available from 28. 11. 2022: https://www.nice.org.uk/guidance/ng188
18. Kalia R., Kalia R., Musih J., Cubelo M., & Popat J. Post-COVID-19 Syndrome: A Novel Diagnosis. Cureus. 148. DOI: 10.7759/cureus.28266
19. Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021. 245. DOI: 10.1016/j.eclinm.2021.100899.
20. Pinato D.J., Tabernero J., Bower M., et al.; OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021. 2212. DOI: 10.1016/S1470-2045(21)00573-8.
Review
For citations:
Kayukova E.V., Bolotov E.S. Post-COVID syndrome in cancer patients. Transbaikalian Medical Bulletin. 2023;(1):149-155. (In Russ.) https://doi.org/10.52485/19986173_2023_1_149
Views:
130
Email this article 